Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Bull Exp Biol Med ; 175(1): 23-26, 2023 May.
Artigo em Inglês | MEDLINE | ID: mdl-37338757

RESUMO

We studied the possibility of inhibition of histone deacetylases (HDAC) in the nuclear extract of HeLa cells by N1-hydroxy-N4-(pyridin-4-yl)succinamide (compound 1). Compound 1 inhibits HDAC and showed low toxicity for A-172, HepG2, HeLa, MCF-7, and Vero cells. HeLa cells were most sensitive to the compound. Increasing the interval between administration of compound 1 and the chemotherapeutic agent to 8 h led to an increase in the cytotoxic effect of cisplatin (actinomycin D) on HeLa cells. The combination of compound 1 with cisplatin (actinomycin D) reduced the cytotoxic effect of these drugs for non-tumor Vero cells.


Assuntos
Antineoplásicos , Cisplatino , Animais , Chlorocebus aethiops , Humanos , Cisplatino/farmacologia , Dactinomicina/farmacologia , Ácido Succínico , Células HeLa , Células Vero , Antineoplásicos/farmacologia , Piridinas/farmacologia , Inibidores de Histona Desacetilases/farmacologia , Linhagem Celular Tumoral
2.
Bull Exp Biol Med ; 169(2): 249-253, 2020 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-32651830

RESUMO

We measured the content of ROS and malondialdehyde in cells of in vivo drug-resistant murine P388 leukemia strains. It was found that the strains did not differ by malondialdehyde concentration, but intracellular concentration of ROS in cells of the cyclophosphamide-resistant strain (P388/CP) was higher than in cells of the original (P388) and other studied strains (P388/Rub, P388/cPt). Nuclear localization of the transcription factor Nrf2 in cells of strain P388/CP attested to its constitutive activation. Enhanced relative expression of the GCLM gene was found in all studied drug-resistant strains; the expression of the GSR and GPX1 genes was increased only in cells of the cyclophosphamide-resistant strain. These findings suggest that the mechanism of resistance of strain P388/CP is associated with increased activity of glutathione metabolism that developed as a result of activation of the antioxidant response transcription factor Nrf2 against the background of high intracellular concentration of ROS.


Assuntos
Glutationa/metabolismo , Fator 2 Relacionado a NF-E2/metabolismo , Animais , Antioxidantes/metabolismo , Linhagem Celular Tumoral , Ciclofosfamida/metabolismo , Malondialdeído/metabolismo , Camundongos , Oxirredução , Espécies Reativas de Oxigênio/metabolismo
3.
Bull Exp Biol Med ; 169(1): 169-175, 2020 May.
Artigo em Inglês | MEDLINE | ID: mdl-32504383

RESUMO

The effect of inhibition of the tumor suppressor p53 on the antioxidant system genes expression under the influence of cytotoxic compounds of the platinum group was studied. It was found that the action of platinum(II) and platinum(IV) complexes induced accumulation of p53 protein with a maximum in 12 h, which was confirmed by an increase in the expression of the P21 gene, the target gene of the p53 protein. It was shown that the action of platinum complexes activated the expression of catalase and superoxide dismutase 2 genes. Suppression of p53 protein functions with specific inhibitor α-piphitrin under the action of platinum complexes reduced the expression of catalase and superoxide dismutase 2 genes and the target gene P21, which attested to the p53-dependent regulation of these genes.


Assuntos
Antineoplásicos/farmacologia , Antioxidantes/metabolismo , Proteína Supressora de Tumor p53/fisiologia , Apoptose/efeitos dos fármacos , Apoptose/genética , Catalase/efeitos dos fármacos , Catalase/genética , Sobrevivência Celular/efeitos dos fármacos , Sobrevivência Celular/genética , Inibidor de Quinase Dependente de Ciclina p21/genética , Enzimas Reparadoras do DNA/genética , Regulação Enzimológica da Expressão Gênica/efeitos dos fármacos , Regulação Neoplásica da Expressão Gênica , Humanos , Células MCF-7 , Estresse Oxidativo/efeitos dos fármacos , Estresse Oxidativo/genética , Espécies Reativas de Oxigênio/metabolismo , Superóxido Dismutase/efeitos dos fármacos , Superóxido Dismutase/genética , Proteína Supressora de Tumor p53/genética
4.
Bull Exp Biol Med ; 167(3): 339-342, 2019 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-31346869

RESUMO

Activities of superoxide dismutase and catalase and content of reduced glutathione in cells of drug-resistant murine leukemia P388 strains were studied without or after administration of antitumor compounds. In the absence of chemotherapeutic agents, no significant differences in activities of the studied enzymes in cells of the initial strain and strains resistant to cyclophosphamide, cisplatin, and rubomycin were observed. Compounds to which resistance was developed did not significantly affect activity of enzymes in cells of drug-resistant strains, while the use of compounds that were not resistance inductors was accompanied by a significant decrease in enzyme activity in cells resistant to cisplatin and rubomycin. In cells of strains resistant to cisplatin and cyclophosphamide, the content of reduced glutathione significantly differed from that in the initial strain. In addition, the concentration of reduced glutathione in cells of cyclophosphamide-resistant strain considerably decreased upon addition of the drug producing a therapeutic effect. Our findings suggest that the mechanism of resistance of in vivo derived cyclophosphamide resistant cell strain is related to increased level of reduced glutathione and activity of its metabolism.


Assuntos
Antineoplásicos/farmacologia , Catalase/metabolismo , Resistencia a Medicamentos Antineoplásicos/fisiologia , Glutationa/análise , Leucemia P388/tratamento farmacológico , Superóxido Dismutase/metabolismo , Animais , Antioxidantes/metabolismo , Linhagem Celular Tumoral , Cisplatino/farmacologia , Ciclofosfamida/farmacologia , Daunorrubicina/farmacologia , Doxorrubicina/farmacologia , Camundongos , Camundongos Endogâmicos DBA , Espécies Reativas de Oxigênio/metabolismo
5.
Bull Exp Biol Med ; 166(6): 779-784, 2019 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-31028582

RESUMO

The cytotoxicity and antioxidant effects of chitosan-(poly)nitoxides of different molecular weights containing a nitroxide radical of the piperidine structure were studied on tumor (HeLa, A172, and HepG2) and normal (Vero) cell lines. The chitosan-(poly)nitroxides exhibited low cytotoxicity. Under conditions of oxidative stress induced with tert-butyl hydroperoxide, the most pronounced decrease in ROS levels in the presence of chitosan-(poly)nitroxides was observed in normal cells. In cell homogenates, the decrease in malondialdehyde levels was observed only in the presence of low-molecular-weight chitosan-(poly)nitroxide irrespective of the cell line. Our data demonstrate that the cell-specific antioxidant properties of chitosan-(poly)nitroxides are related to their penetration into cells and interaction with intracellular membranes.


Assuntos
Antioxidantes/farmacologia , Quitosana/farmacologia , Óxidos de Nitrogênio/química , Estresse Oxidativo/efeitos dos fármacos , Piperidinas/farmacologia , Animais , Antioxidantes/síntese química , Linhagem Celular Tumoral , Quitosana/análogos & derivados , Quitosana/síntese química , Chlorocebus aethiops , Células HeLa , Células Hep G2 , Humanos , Neuroglia/efeitos dos fármacos , Neuroglia/metabolismo , Neuroglia/patologia , Especificidade de Órgãos , Piperidinas/síntese química , Espécies Reativas de Oxigênio/antagonistas & inibidores , Espécies Reativas de Oxigênio/metabolismo , Relação Estrutura-Atividade , Células Vero , terc-Butil Hidroperóxido/antagonistas & inibidores , terc-Butil Hidroperóxido/farmacologia
6.
Bull Exp Biol Med ; 161(1): 179-83, 2016 May.
Artigo em Inglês | MEDLINE | ID: mdl-27265137

RESUMO

We studied the function of the antioxidant system in tumor cell lines MCF-7 and H1299 that differ by the state of tumor suppressor gene p53. Exposure to different classes of cytotoxic compounds induced several types of antioxidant system responses that depend on the type of cell line. The effects of platinum(II) and platinum(IV) complexes on activity of antioxidant enzymes vary, which can be explained by differences in their accumulation and biotransformation in tumor cells. Triazole and oxazolidinone derivatives had little effect on activity of superoxide dismutase and catalase in H1299 cells, but increased superoxide dismutase activity in MCF-7 cells.


Assuntos
Antineoplásicos/toxicidade , Catalase/metabolismo , Cisplatino/toxicidade , Compostos Organoplatínicos/toxicidade , Superóxido Dismutase/metabolismo , Indução Enzimática , Humanos , Concentração Inibidora 50 , Células MCF-7 , Estresse Oxidativo , Espécies Reativas de Oxigênio/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...